Most of the better-known targets of prosecution under the U.S. False Claims Act (FCA) are drug and device manufacturers, but the Department of Justice (DOJ) seems to have opened a new front in the war on Medicare fraud.

Read Full Story: https://www.bioworld.com/articles/516147-reimbursement-consultant-snared-in-p...